Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors
  • Library

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, China
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Our sub-categories
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2025
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Galderma Insights
    • Podcasts
  • Innovation
    • Bringing innovation to life
    • Partnerships
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Investors
You searched for: «【✈️ Telegram ID: KPU77】 성피찾기 성인피씨방 안전 보장 100% 알거래 중개소 리스트 - 양주»
Results 121 - 125 of 156
Page 25 of 32
  1. Media
  2. Newsroom

Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%, the First New Retinoid Molecule for the Treatment of Acne in Over 20 Years

Next-Generation Treatment is First Option Studied and Proven Effective in Both Facial and Truncal Acne

  1. Media
  2. Newsroom

Galderma’s Restylane® Volyme™ demonstrates high effectiveness, satisfaction and a robust safety profile in Chinese patients with temple hollowing

  • Positive topline results showed that Restylane Volyme (known as Restylane Contour in the U.S.) was highly effective in the correction of moderate-to-severe temple hollowing, with high responder rates maintained through Month 121 
  • Re
  1. Media
  2. Newsroom

New study reveals the impact of ‘hidden acne’ on quality of life

  • Around 60% of patients with facial acne also have truncal involvement1 however truncal acne is often overlooked in consultations2
  • This study, which examined the quality of life of >1300 acne sufferers with either facial acne alone or combined truncal and facial acne, reported that combined tr
  1. Media
  2. Newsroom

Fort Worth’s Galderma, Maker of Cetaphil, Presents the 4th Annual Wonder Run 5K and 1K Kids Waddle to Benefit Children’s Skin Disease Foundation

Cetaphil is Long-Term Provider of Products Essential to Children with Skin Diseases

 

  1. Media
  2. Newsroom

Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting

Company announces Phase 3 READY program of its proprietary, novel, liquid formulation of an investigational botulinum toxin for the treatment of glabellar lines and lateral canthal lines is fully enrolled

Results 121 - 125 of 156
Page 25 of 32

Pagination

  • Previous page Previous Page
  • Next page Next Page
  1. Home
  2. Search results

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2026

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back